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Genetics of Innate Immunity
B. Beutler
The Scripps Research Institute, La Jolla, CA, USA
The general sensing apparatus used by the mammalian
innate immune systemwas ﬁrst revealed by a classical muta-
tion, affecting the so-called Lps locus of mice. Positional
cloning disclosed that Lps mutants, which were unable to
sense bacterial lipopolysaccharides (LPS), had defects in
Toll-like receptor 4, which thus emerged as the key trans-
ducing component of the LPS receptor. It is now known
that awareness of microbes depends upon a small collec-
tion of germline-encoded receptors that are rather ﬂexible
in their recognition speciﬁcity and collectively discrimi-
nate between self and non-self. Mammals depend upon
the TLRs to such an extent that mice lacking TLRs are
quickly overwhelmed by a wide variety of infections. We
have applied a classical genetic approach (mutagenesis and
positional cloning) to analyze innate immunity in mice.
Among the phenomena probed are Toll-like receptor sig-
nal transduction and resistance to infection by mouse
cytomegalovirus (MCMV), a herpesvirus that has unusually
sharp dose-lethality characteristics in the host species.
Where TLR signaling is concerned, total of 22 mutations
affecting 18 genes have been identiﬁed by screening approx-
imately 30,000 mice. These mutations delineate much of
what we know about how the mouse becomes aware of
infection and begins to mount a response. With regard
to the MCMV resistance screen, 46 phenovariants have
been collected from among 22,000 mice screened to date.
These affect genes in ﬁve functional categories, classed as
‘sensing’, signaling’, ‘effector’, ‘homeostatic’, and ‘devel-
opmental’. Through positional cloning, we have identiﬁed
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inimum of 300 genes and perhaps more than 1000 genes
ake non-redundant contributions to defense against MCMV.
e hope to identify all of these genes and determine how
hey operate together to protect the host.
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. Lubroth ∗, J. Domenech
FAO, Rome, Italy
here are very few diseases that have spread as fast
nd wide among its hosts as the Eurasian strain H5N1 of
vian inﬂuenza virus. Currently over 60 countries have
eported H5N1 HPAI introduction since it ﬁrst emerged
s a transboundary animal disease crisis in late 2003.
he misguided panic of an imminent human pandemic led
overnment, regional and international organisations, ﬁnan-
ial and donor institutions to stress preparedness planning
ncluding accumulation of anti-virals and vaccines forget-
ing that the origin of the malady was - and remains -
poultry problem. Notwithstanding the important efforts
or preparedness for a human pandemic, the veterinary
ational and international efforts to prevent, detect, and
ontrol the H5N1 highly pathogenic avian inﬂuenza strain
mphasised ‘‘tackling the disease at source’’, but funding
nterests lagged and the country’s national veterinary ser-
ices were unable to mount sufﬁcient border and regulatory
ontrols to keep the disease in South East Asia. Notable
isks were trade - some of it legal - poor hygienic condi-
ions in an under-regulated poultry production systems and
